1. Home
  2. PALI

PALI

Palisade Bio Inc.

Logo Palisade Bio Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Founded: 1996 Country:
United States
United States
Employees: N/A City: CARLSBAD
Market Cap: 3.7M IPO Year: N/A
Target Price: $131.25 AVG Volume (30 days): 694.8K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -27.00 EPS Growth: N/A
52 Week Low/High: $3.82 - $36.60 Next Earning Date: 05-10-2024
Revenue: $250,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: